Telatinib sustained-release implantation agent for treating solid tumors
The invention relates to a teratinib sustained release implant for treating solid tumors, which is characterized in that the sustained release implant contains teratinib and sustained-release excipient of effective anticancer amount and certain amount of sustained release regulator. The solid tumors...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!